Cargando…
Angiogenic Potential of Bone Marrow Derived CD133(+) and CD271(+) Intramyocardial Stem Cell Trans- Plantation Post MI
Background: Bone marrow (BM)-derived stem cells with their various functions and characteristics have become a well-recognized source for the cell-based therapies. However, knowledge on their therapeutic potential and the shortage for a cross-link between distinct BM-derived stem cells, primed after...
Autores principales: | Sasse, Sarah, Skorska, Anna, Lux, Cornelia Aquilina, Steinhoff, Gustav, David, Robert, Gaebel, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016579/ https://www.ncbi.nlm.nih.gov/pubmed/31892273 http://dx.doi.org/10.3390/cells9010078 |
Ejemplares similares
-
CD271(+) Human Mesenchymal Stem Cells Show Antiarrhythmic Effects in a Novel Murine Infarction Model
por: Sadraddin, Haval, et al.
Publicado: (2019) -
GMP-conformant on-site manufacturing of a CD133(+) stem cell product for cardiovascular regeneration
por: Skorska, Anna, et al.
Publicado: (2017) -
Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells
por: Lemcke, Heiko, et al.
Publicado: (2017) -
Cardiac Function Improvement and Bone Marrow Response –: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction
por: Steinhoff, Gustav, et al.
Publicado: (2017) -
Dose-Independent Therapeutic Benefit of Bone Marrow Stem Cell Transplantation after MI in Mice
por: Zarniko, Nicole, et al.
Publicado: (2020)